Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		242,738,000
Beginning balance at Dec. 31, 2021	$ 929,787	$ 24	$ 1,515,748	$ (1,623)	$ (584,362)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		2,138,000
Issuance of common stock upon exercise of stock options	4,125	$ 1	4,124
Issuance of common stock under employee stock purchase plan (in shares)		284,000
Issuance of common stock under employee stock purchase plan	887		887
Stock-based compensation (in shares)		1,950,000
Stock-based compensation	44,438		44,438
Other comprehensive income (loss)	(6,728)			(6,728)
Net loss	(104,467)				(104,467)
Ending balance (in shares) at Jun. 30, 2022		247,110,000
Ending balance at Jun. 30, 2022	868,042	$ 25	1,565,197	(8,351)	(688,829)
Beginning balance (in shares) at Mar. 31, 2022		245,423,000
Beginning balance at Mar. 31, 2022	881,249	$ 25	1,540,330	(6,600)	(652,506)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		428,000
Issuance of common stock upon exercise of stock options	1,570		1,570
Issuance of common stock under employee stock purchase plan (in shares)		284,000
Issuance of common stock under employee stock purchase plan	887		887
Stock-based compensation (in shares)		975,000
Stock-based compensation	22,410		22,410
Other comprehensive income (loss)	(1,751)			(1,751)
Net loss	(36,323)				(36,323)
Ending balance (in shares) at Jun. 30, 2022		247,110,000
Ending balance at Jun. 30, 2022	$ 868,042	$ 25	1,565,197	(8,351)	(688,829)
Beginning balance (in shares) at Dec. 31, 2022	249,567,343	249,567,000
Beginning balance at Dec. 31, 2022	$ 833,252	$ 25	1,608,306	(7,599)	(767,480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	832,840	833,000
Issuance of common stock upon exercise of stock options	$ 83		83
Issuance of common stock under employee stock purchase plan (in shares)		543,000
Issuance of common stock under employee stock purchase plan	1,163		1,163
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		84,000
Issuance of common stock in connection with restricted stock units, net of tax	(119)		(119)
Stock-based compensation	28,105		28,105
Other comprehensive income (loss)	5,220			5,220
Net loss	$ (130,849)				(130,849)
Ending balance (in shares) at Jun. 30, 2023	251,026,997	251,027,000
Ending balance at Jun. 30, 2023	$ 736,855	$ 25	1,637,538	(2,379)	(898,329)
Beginning balance (in shares) at Mar. 31, 2023		249,609,000
Beginning balance at Mar. 31, 2023	783,826	$ 25	1,622,119	(3,879)	(834,439)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		833,000
Issuance of common stock upon exercise of stock options	83		83
Issuance of common stock under employee stock purchase plan (in shares)		543,000
Issuance of common stock under employee stock purchase plan	1,163		1,163
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		42,000
Issuance of common stock in connection with restricted stock units, net of tax	(50)		(50)
Stock-based compensation	14,223		14,223
Other comprehensive income (loss)	1,500			1,500
Net loss	$ (63,890)				(63,890)
Ending balance (in shares) at Jun. 30, 2023	251,026,997	251,027,000
Ending balance at Jun. 30, 2023	$ 736,855	$ 25	$ 1,637,538	$ (2,379)	$ (898,329)